Impairment of α1-adrenoceptor-mediated contractile activity in caudal arterial smooth muscle from Type 2 diabetic Goto-Kakizaki rats

Clinical and Experimental Pharmacology and Physiology

Volumn 37, Issue 3, 2010, Pages 350-357

  Mita, Mitsuo ^a   Kuramoto, Takuto ^a   Ito, Kazushi ^a   Toguchi Senrui, Natsuko ^a   Hishinuma, Shigeru ^a   Walsh, Michael P ^b   Shoji, Masaru ^a  

^a MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

1 adrenoceptors; Ca2+ mobilization; Diabetes; Goto Kakizaki rats; Vascular smooth muscle

Indexed keywords

CAFFEINE; CALCIUM; CIRAZOLINE; GLUCOSE; INSULIN; MESSENGER RNA; MYOSIN LIGHT CHAIN; POTASSIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY MUSCLE; ARTICLE; CONTROLLED STUDY; EXTRACELLULAR CALCIUM; GLUCOSE BLOOD LEVEL; GOTO KAKIZAKI RAT; HYPERGLYCEMIA; HYPOINSULINEMIA; INSULIN BLOOD LEVEL; MALE; MEMBRANE DEPOLARIZATION; MUSCLE CONTRACTILITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PROTEIN PHOSPHORYLATION; RAT; SARCOPLASMIC RETICULUM; SMOOTH MUSCLE;

ADRENERGIC ALPHA-1 RECEPTOR AGONISTS; ANIMALS; ARTERIES; DIABETES MELLITUS, TYPE 2; IMIDAZOLES; MALE; MUSCLE, SMOOTH, VASCULAR; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, ALPHA-1; VASOCONSTRICTION;

EID: 77649153747     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2009.05308.x     Document Type: Article

References (51)

1. Öztürk Y, Altan VM, Yildizoglu-Ali N. Effects of experimental diabetes and insulin on smooth muscle functions. Pharmacol. Rev. 1996 48 : 69 112.
2. Altura BM, Halevy S, Turlapaty PD. Vascular smooth muscle in diabetes and its influence on the reactivity of blood vessels. In : Davis E (ed The Microcirculation in Diabetes. Karger, Basel. 1979 118 150.
3. Chaudhuri A. Vascular reactivity in diabetes mellitus. Curr. Diab. Rep. 2002 2 : 305 310.
4. 2, but not noradrenaline, of aortae from rats with streptozotocin-induced diabetes mellitus. Br. J. Pharmacol. 1991 104 : 928 932.
5. 2 receptor-mediated contraction of tail arteries from normal or streptozotocin-induced diabetic rats. Br. J. Pharmacol. 1998 125 : 143 151.
6. Makino A, Kamata K. Effects of chronic administration of l-arginine on vasoactive responses induced by endothelin-1 and its plasma level in streptozotocin-induced diabetic rats. J. Smooth Muscle Res. 2002 38 : 101 115.
7. Carvalho Leone AF, Coelho EB. Effects of prostanoids on phenylephrine-induced contractions in the mesenteric vascular bed of rats with streptozotocin-induced diabetes mellitus. Life Sci. 2004 76 : 239 247.
8. i signaling. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2006 290 : R145 53.
9. 2+ mobilization in aortic smooth muscle cells from streptozotocin-induced diabetic rats. Clin. Exp. Pharmacol. Physiol. 2008 35 : 568 573.
10. Abebe W, Harris KH, MacLeod KM. Enhanced contractile responses of arteries from diabetic rats to alpha 1-adrenoceptor stimulation in the absence and presence of extracellular calcium. J. Cardiovasc. Pharmacol. 1990 16 : 239 248.
11. White RE, Carrier GO. Vascular contraction induced by activation of membrane calcium ion channels is enhanced in streptozotocin-diabetes. J. Pharmacol. Exp. Ther. 1990 253 : 1057 1062.
12. Inazu M, Sakai Y, Homma I. Contractile responses and calcium mobilization in renal arteries of diabetic rats. Eur. J. Pharmacol. 1991 203 : 79 84.
13. Nobe K, Sakai Y, Nobe H, Momose K. Dysfunction of aorta involves different patterns of intracellular signaling pathways in diabetic rats. Eur. J. Pharmacol. 2003 471 : 195 204.
14. Okon EB, Szado T, Laher I, McManus B, van Breemen C. Augmented contractile response of vascular smooth muscle in a diabetic mouse model. J. Vasc. Res. 2003 40 : 520 530.
15. Xavier FE, Davel AP, Rossoni LV, Vassallo DV. Time-dependent hyperreactivity to phenylephrine in aorta from untreated diabetic rats: Role of prostanoids and calcium mobilization. Vascul. Pharmacol. 2003 40 : 67 76.
16. Alabadí JA, Miranda FJ, Lloréns S, Centeno JM, Marrachelli VG, Alborch E. Mechanisms underlying diabetes enhancement of endothelin-1-induced contraction in rabbit basilar artery. Eur. J. Pharmacol. 2004 486 : 289 296.
17. 1 receptors and L-type calcium channels: Functional coupling in supersensitivity to angiotensin II in diabetic rats. Cardiovasc. Res. 2005 65 : 374 386.
18. Mulhern M, Docherty JR. Effects of experimental diabetes on the responsiveness of rat aorta. Br. J. Pharmacol. 1989 97 : 1007 1012.
19. Kobayashi T, Kamata K. Effect of insulin treatment on smooth muscle contractility and endothelium-dependent relaxation in rat aortae from established STZ-induced diabetes. Br. J. Pharmacol. 1999 127 : 835 842.
20. Arikawa E, Verma S, Dumont AS, McNeill JH. Chronic bosentan treatment improves renal artery vascular function in diabetes. J. Hypertens. 2001 19 : 803 812.
21. Diederich D, Skpec J, Diederich A, Dai FX. Endothelial dysfunction in mesenteric resistance arteries of diabetic rats: Role of free radicals. Am. J. Physiol. 1994 266 : H1153 61.
22. De Vriese AS, Verbeuren TJ, Van de Voorde J, Lameire NH, Vanhoutte PM. Endothelial dysfunction in diabetes. Br. J. Pharmacol. 2000 130 : 963 974.
23. Cheng ZJ, Vaskonen T, Tikkanen I et al. Endothelial dysfunction and salt-sensitive hypertension in spontaneously diabetic Goto-Kakizaki rats. Hypertension 2001 37 : 433 439.
24. Witte K, Kacke K, Stahrenberg R et al. Dysfunction of soluble guanylyl cyclase in aorta and kidney of Goto-Kakizaki rats: Influence of age and diabetic state. Nitric Oxide 2002 6 : 85 95.
25. Witte K, Reitenbach I, Stolpe K, Schilling L, Kirchengast M, Lemmer B. Effects of the endothelin A receptor antagonist darusentan on blood pressure and vascular contractility in type 2 diabetic Goto-Kakizaki rats. J. Cardiovasc. Pharmacol. 2003 41 : 890 896.
26. Bitar MS, Wahid S, Mustafa S, Al-Saleh E, Shaunsi GS, Al-Mulla F. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes. Eur. J. Pharmacol. 2005 511 : 53 64. (Pubitemid 40380644)
27. Brøndum E, Nilsson H, Aalkjaer C. Functional abnormalities in isolated arteries from Goto-Kakizaki and streptozotocin-treated diabetic rat models. Horm. Metab. Res. 2005 37 (Suppl. 1 56 60.
28. Goto Y, Kakizaki M, Masaki N. Spontaneous diabetes produced by selective breeding of normal Wistar rats. Proc. Jpn Acad. 1975 51 : 80 5.
29. Goto Y, Kakizaki M, Masaki N. Production of spontaneous diabetic rats by repetition of selective breeding. Tohoku J. Exp. Med. 1976 119 : 85 90.
30. Oniki H, Fujii K, Kansui Y, Goto K, Iida M. Effects of angiotensin II receptor antagonist on impaired endothelium-dependent and endothelium- independent relaxations in type II diabetic rats. J. Hypertens. 2006 24 : 331 338.
31. Rösen P, Wiernsperger NF. Metformin delays the manifestation of diabetes and vascular dysfunction in Goto-Kakizaki rats by reduction of mitochondrial oxidative stress. Diabetes Metab. Res. Rev. 2006 22 : 323 330.
32. 2D-adrenoceptor and eNOS in aortas from early and later stages of diabetes in Goto-Kakizaki rats. Am. J. Physiol. Heart Circ. Physiol. 2004 287 : H135 43.
33. 1-Adrenoceptor-mediated phosphorylation of myosin in rat-tail arterial smooth muscle. Biochem. J. 1997 327 : 669 674.
34. Mita M, Yanagihara H, Hishinuma S, Saito M, Walsh MP. Membrane depolarization-induced contraction of rat caudal arterial smooth muscle involves Rho-associated kinase. Biochem. J. 2002 364 : 431 440.
35. Sowers JR. Insulin resistance and hypertension. Am. J. Physiol. Heart Circ. Physiol. 2004 286 : H1597 602.
36. Bolton TB, Presywich SS, Zoholos AV, Gordienko DV. Excitation-contraction coupling in gastrointestinal and other smooth muscles. Annu. Rev. Physiol. 1999 61 : 85 115.
37. Allen BG, Walsh MP. The biochemical basis of the regulation of smooth-muscle contraction. Trends Biochem. Sci. 1994 19 : 362 368.
38. 2+ in the selective enhancement of contractile responses of arteries from diabetic rats to noradrenaline. Can. J. Physiol. Pharmacol. 1994 72 : 1544 1551.
39. Carmines PK, Ohishi K, Ikenaga H. Functional impairment of renal afferent arteriolar voltage-gated calcium channels in rats with diabetes mellitus. J. Clin. Invest. 1996 98 : 2564 2571.
40. 2+ channel currents in vascular smooth muscle cells from experimental diabetic rats. Am. J. Physiol. Heart Circ. Physiol. 2000 278 : H714 22.
41. Hill B, Price E, Dixon J, Sturek M. Increased calcium buffering in coronary smooth muscle cells from diabetic dyslipidemic pigs. Atherosclerosis 2003 167 : 15 23.
42. 1-Adrenergic receptor subtypes. Molecular structure, function, and signaling. Circ. Res. 1996 78 : 737 749.
43. Weber LP, Seto M, Sasaki Y, Swärd K, Walsh MP. The involvement of protein kinase C in myosin phosphorylation and force development in rat tail arterial smooth muscle. Biochem. J. 2000 352 : 573 582.
44. Jatifpour J, Gousse A, Kondo S, Motira T, Weiss RM. Effect of experimental diabetes on biochemical and functional characteristics of bladder muscarinic receptors. J. Pharmacol. Exp. Ther. 1989 248 : 81 8.
45. Weber LP, MacLeod KM. Influence of streptozotocin diabetes on the alpha-1 adrenoceptor and associated G proteins in rat arteries. J. Pharmacol. Exp. Ther. 1997 283 : 1469 1478.
46. Worley JF, Kotlikoff MI. Dihydropyridine-sensitive single calcium channels in airway smooth muscle cells. Am. J. Physiol. 1990 259 : L468 80.
47. Murray RK, Kotlikoff MI. Receptor-activated calcium influx in human airway smooth muscle cells. J. Physiol. 1991 435 : 123 144.
48. Parekh AB, Putney JW Jr. Store-operated calcium channels. Physiol. Rev. 2005 85 : 757 810.
49. 2+ uptake in rat retinal microvascular smooth muscle. Diabetologia 2003 46 : 1252 1259.
50. 3)- and ryanodine-sensitive calcium stores in rat basilar artery vasomotion. J. Physiol. 2002 545 : 615 627.
51. Iino M. Calcium-induced calcium release mechanism in guinea pig taenia caeci. J. Gen. Physiol. 1989 94 : 363 383.